Oxidative stress: link between hypertension and diabetes

참고문헌 (19)

1. Cheung BM, "Diabetes and hypertension: is there a common metabolic pathway?", Curr Atheroscler Rep, 14, pp.160~166 (2012)
2. Latha Ramalingam, "The renin angiotensin system, oxidative stress and mitochondrial function in obesity and insulin resistance", Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1863(5), pp.1106~1114 (2017), Elsevier BV[DOI]
3. Manucha W, "Hypertension and insulin resistance: implications of mitochondrial dysfunction", Curr Hypertens Rep, 17, pp.504~ (2015)
4. Hsieh TJ, "High glucose stimulates angiotensinogen gene expression via reactive oxygen species generation in rat kidney proximal tubular cells", Endocrinology, 143, pp.2975~2985 (2002)
5. Moon JS, "Metformin prevents glucotoxicity by alleviating oxidative and ER stress-induced CD36 expression in pancreatic beta cells", J Diabetes Complications, 31, pp.21~30 (2017)
6. Poitout V, "Glucolipotoxicity: fuel excess and beta-cell dysfunction", Endocr Rev, 29, pp.351~366 (2008)
7. Lupi R, "The direct effects of the angiotensin-converting enzyme inhibitors, zofenoprilat and enalaprilat, on isolated human pancreatic islets", Eur J Endocrinol, 154, pp.355~361 (2006)
8. NAVIGATOR Study Group, "Effect of valsartan on the incidence of diabetes and cardiovascular events", N Engl J Med, 362, pp.1477~1490 (2010)
9. van der Zijl NJ, "Valsartan improves {beta}-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial", Diabetes Care, 34, pp.845~851 (2011)
10. Kurata A, "Blockade of Angiotensin II type-1 receptor reduces oxidative stress in adipose tissue and ameliorates adipocytokine dysregulation", Kidney Int, 70, pp.1717~1724 (2006)
11. Wei Y, "Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells", J Biol Chem, 281, pp.35137~35146 (2006)
12. Macconi D, "Sirtuin3 dysfunction is the key determinant of skeletal muscle insulin resistance by angiotensin II", PLoS One, 10, pp.e0127172~ (2015)
13. Mason RP, "Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine", J Mol Cell Cardiol, 31, pp.275~281 (1999)
14. Ganafa AA, "Amlodipine attenuates oxidative stress-induced hypertension", Am J Hypertens, 17, pp.743~748 (2004)
15. Hirooka Y, "Effects of valsartan or amlodipine on endothelial function and oxidative stress after one year follow-up in patients with essential hypertension", Clin Exp Hypertens, 30, pp.267~276 (2008)
16. Aslam S, "Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis", Kidney Int, 70, pp.2109~2115 (2006)
17. 김해진, "Effects of valsartan and amlodipine on oxidative stress in type 2 diabetic patients with hypertension: a randomized, multicenter study", The Korean Journal of Internal Medicine, 32(3), pp.497~504 (2017), 대한내과학회[DOI]
18. Mihalj M, "Blood pressure reduction is associated with the changes in oxidative stress and endothelial activation in hypertension, regardless of antihypertensive therapy", Kidney Blood Press Res, 41, pp.721~735 (2016)
19. Vivekananthan DP, "Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials", Lancet, 361, pp.2017~2023 (2003)

관련 논문AI추천